Form 8-K Flyte Aviation, Inc. For: Oct 05

false 0001716621 0001716621 2026-10-05 2026-10-05

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):

 

October 5, 2026

 

Flyte Aviation, Inc.

(Exact name of registrant as specified in its charter)

 

 

1670 Highway 160 West

Suite 205

Fort Mill, SC 29708

(Address of principal executive offices, including zip code)

 

(973) 691-2000

(Registrant’s telephone number, including area code)

 

Catheter Precision, Inc.

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

Item 7.01 Regulation FD Disclosure.

 

On October 5, 2026, Flyte Aviation, Inc. (formerly known as Catheter Precision, Inc.) (the “Company”) issued a press release titled “Flyte Aviation Launches Under NYSE American Ticker ‘VJET’.” A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

 

The information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

 

Item 8.01           Other Events.

 

As previously reported, effective at 12:01 a.m., Eastern Time, on October 5, 2026, the Company changed its name from “Catheter Precision, Inc.” to “Flyte Aviation, Inc.” and effected a 1-for-10 reverse stock split of its common stock, par value $0.0001 per share (the “Common Stock”). The Common Stock began trading on the NYSE American under the new ticker symbol “VJET” on a split-adjusted basis at the opening of trading on October 5, 2026, under the new CUSIP number 74933X 807.

 

Following the reverse stock split, the Company has approximately 2,101,987 shares of Common Stock issued and outstanding, subject to the cash-out of fractional shares.

 

Item 9.01 Financial Statements and Exhibits. 

 

(d) Exhibits.

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.